Scholarly Works

Hepatitis B, Rituximab, Screening, and...

Journal article

Hepatitis B, Rituximab, Screening, and Prophylaxis: Effectiveness and Cost Effectiveness

Authors

Hay AE; Meyer RM

Journal

Journal of Clinical Oncology, Vol. 30, No. 26, pp. 3155–3157

Publisher

American Society of Clinical Oncology (ASCO)

Publication Date

September 10, 2012

DOI

10.1200/jco.2012.43.7509

ISSN

0732-183X

Associated Experts

Ralph Meyer

Professor Emeritus, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3211 Oncology and carcinogenesis

Medical Subject Headings (MeSH)

Antibodies, Monoclonal, Murine-Derived Antineoplastic Combined Chemotherapy Protocols Cost-Benefit Analysis Cyclophosphamide Doxorubicin Early Diagnosis Hepatitis B Humans Lymphoma, Large B-Cell, Diffuse Prednisone Rituximab Vincristine

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback